Skip to main content
. Author manuscript; available in PMC: 2013 Mar 20.
Published in final edited form as: Cancer Cell. 2012 Mar 20;21(3):418–429. doi: 10.1016/j.ccr.2012.01.007

Table 1. Summary of metastatic disease burden in KPC mice.

Treatment % mice
with mets		 # macroscopic mets /
mouse (mean+/−S.E.M.)		 # mets / mouse
(mean+/−S.E.M.)		 % mice with
liver mets		 % mice with lung
mets		 % mice with
diaphragm mets		 % lymph node
involvement		 % mice with
malignant
ascites
Gem+Placebo 93 1.7 +/− 0.35 2.4 +/− 0.35 73 40 40 73 47
Gem+PEGPH20 43 0.86 +/− 0.4 1.1 +/− 0.4 43 21 21 36 21